The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Accelerated Variant of Idiopathic Pulmonary Fibrosis: Clinical Behavior and Gene Expression Pattern
Open accessAbstract
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is characterized by the insidious onset of dyspnea or cough. However, a subset of patients has a short duration of symptoms with rapid progression to end-stage disease. In this study, we evaluated clinical and molecular features of "rapid" and "slow" progressors with IPF. METHODS AND FINDINGS: 26 patients with <6 months of symptoms before first presentation [rapid progressors] and 88 patients with >24 months of symptoms [slow progressors] were studied. Survival was analyzed by the Kaplan-Meyer method and proportional hazard's model. Lung microarrays and tissue proteins were measured in a subset of patients. No differences were found in age, physiologic impairment and bronchoalveolar lavage (BAL) cellular profile. There were more males (OR = 6.5; CI:1.4-29.5; p = 0.006) and smokers (OR = 3.04; CI:1.1-8.3; p = 0.04) in the rapid progressors group. Survival from the beginning of symptoms was significantly reduced in rapid progressors (HR = 9.0; CI:4.48-18.3; p<0.0001) and there was a tendency for decreased survival from the time of diagnosis (HR = 1.5; CI:0.81-2.87; p = 0.18). We identified 437 differentially expressed genes. Lungs of rapid progressors overexpressed genes involved in morphogenesis, oxidative stress, migration/proliferation, and genes from fibroblasts/smooth muscle cells. Upregulation of two of these genes, adenosine-2B receptor and prominin-1/CD133, was validated by immunohistochemistry and were expressed by alveolar epithelial cells. BAL from rapid progressors showed a >2-fold increase of active matrix metalloproteinase-9, and induced a higher fibroblast migration compared with slow progressors and controls [238+/-98% versus 123+/-29% (p<0.05) and 30+/-17% (p<0.01)]. CONCLUSIONS/SIGNIFICANCE: A subgroup of IPF patients, predominantly smoking males, display an accelerated clinical course and have a gene expression pattern that is different from those with slower progression and longer survival. These findings highlight the variability in the progression of IPF, and may explain, in part, the difficulty in obtaining significant and reproducible results in studies of therapeutic interventions in patients with IPF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Yu, Q., & Stamenkovic, I. (2000) · PubMed · Cited by 1,995
Selman, M., King, T. E., & Pardo, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00015 · Cited by 1,786
Self-citationYu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754
Gross, T. J., & Hunninghake, G. W. (2001) · New England Journal of Medicine · doi:10.1056/nejmra003200 · Cited by 962
Predicting Survival in Idiopathic Pulmonary Fibrosis
KING, T. E., TOOZE, J. A., SCHWARZ, M. I., BROWN, K. R., & CHERNIACK, R. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.7.2003140 · Cited by 853
Self-citationinternational consensus statement
Clements, R. V., & Simanowitz, A. (2000) · Cited by 852
Tissue Classification with Gene Expression Profiles
Ben-Dor, A., Bruhn, L., Friedman, N., Nachman, I., Schummer, M., & Yakhini, Z. (2000) · Journal of Computational Biology · doi:10.1089/106652700750050943 · Cited by 741
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
Raghu, G., Brown, K. K., Bradford, W. Z., Starko, K., Noble, P. W., Schwartz, D. A., & King, T. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030511 · Cited by 652
Self-citationThe Clinical Course of Patients with Idiopathic Pulmonary Fibrosis
Martinez, F. J., Safrin, S., Weycker, D., Starko, K. M., Bradford, W. Z., King, T. E., Flaherty, K. R., Schwartz, D. A., Noble, P. W., Raghu, G., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-12_part_1-200506210-00005 · Cited by 622 · cited 4×
“experience a slowly progressive clinical course (‘‘slow’’ progressors) [5].”
BackgroundMethodInfluentialSelf-citationMatrix Metalloproteinase-9 in Lung Remodeling
Atkinson, J. J., & Senior, R. M. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0166tr · Cited by 587
Up-Regulation and Profibrotic Role of Osteopontin in Human Idiopathic Pulmonary Fibrosis
Pardo, A., Gibson, K., Cisneros, J., Richards, T. J., Yang, Y., Becerril, C., Yousem, S., Herrera, I., Ruiz, V., Selman, M., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020251 · Cited by 489
Self-citationKazerooni, E. A., Martinez, F. J., Flint, A., Jamadar, D. A., Gross, B. H., Spizarny, D. L., Cascade, P. N., Whyte, R. I., Lynch, J. P., & Toews, G. (1997) · American Journal of Roentgenology · doi:10.2214/ajr.169.4.9308447 · Cited by 469
Gene Expression Profiles Distinguish Idiopathic Pulmonary Fibrosis from Hypersensitivity Pneumonitis
Selman, M., Pardo, A., Barrera, L., Estrada, A., Watson, S. R., Wilson, K., Aziz, N., Kaminski, N., & Zlotnik, A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200504-644oc · Cited by 458
Self-citationSelman, M., Ruiz, V., Cabrera, S., Segura, L., Ramírez, R., Barrios, R., & Pardo, A. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.3.l562 · Cited by 425
Self-citationIdiopathic Pulmonary Fibrosis: Predicting Response to Therapy and Survival
GAY, S. E., KAZEROONI, E. A., TOEWS, G. B., LYNCH, J. P., GROSS, B. H., CASCADE, P. N., SPIZARNY, D. L., FLINT, A., ANTHONY SCHORK, M., WHYTE, R. I., et al. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9703022 · Cited by 406
From signatures to models: understanding cancer using microarrays
Segal, E., Friedman, N., Kaminski, N., Regev, A., & Koller, D. (2005) · Nature Genetics · doi:10.1038/ng1561 · Cited by 381
Self-citationShmelkov, S. V., St.Clair, R., Lyden, D., & Rafii, S. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.08.010 · Cited by 348
Ning, W., Li, C.-J., Kaminski, N., Feghali-Bostwick, C. A., Alber, S. M., Di, Y. P., Otterbein, S. L., Song, R., Hayashi, S., Zhou, Z., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401168101 · Cited by 328
Self-citationDemling, N., Ehrhardt, C., Kasper, M., Laue, M., Knels, L., & Rieber, E. P. (2006) · Cell and Tissue Research · doi:10.1007/s00441-005-0069-0 · Cited by 249
Fukuda, Y., Ishizaki, M., Kudoh, S., Kitaichi, M., & Yamanaka, N. (1998) · PubMed · Cited by 243
Pérez-Padilla, R., Salas, J., Chapela, R., Sánchez, M., Carrillo, G., Pérez, R., Sansores, R., Gaxiola, M., & Selman, M. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.1.49 · Cited by 222
Self-citationAcute exacerbation of idiopathic pulmonary fibrosis: report of a series
Ambrosini, V., Cancellieri, A., Chilosi, M., Zompatori, M., Trisolini, R., Saragoni, L., & Poletti, V. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00022703 · Cited by 212
A Distinctive Alveolar Macrophage Activation State Induced by Cigarette Smoking
Woodruff, P. G., Koth, L. L., Yang, Y. H., Rodriguez, M. W., Favoreto, S., Dolganov, G. M., Paquet, A. C., & Erle, D. J. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-686oc · Cited by 205
Effect of pirfenidone on the pulmonary fibrosis of Hermansky–Pudlak syndrome
Gahl, W. A., Brantly, M., Troendle, J., Avila, N. A., Padua, A., Montalvo, C., Cardona, H., Anton Calis, K., & Gochuico, B. (2002) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(02)00044-6 · Cited by 203
Modification of gene expression of the small airway epithelium in response to cigarette smoking
Harvey, B.-G., Heguy, A., Leopold, P. L., Carolan, B. J., Ferris, B., & Crystal, R. G. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0103-z · Cited by 181
Antioxidant Gene Polymorphisms and Susceptibility to a Rapid Decline in Lung Function in Smokers
He, J.-Q., Ruan, J., Connett, J. E., Anthonisen, N. R., Paré, P. D., & Sandford, A. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2111059 · Cited by 166
Modification of gene expression of the small airway epithelium in response to cigarette smoking
Harvey, B.-G., Heguy, A., Leopold, P. L., Carolan, B. J., Ferris, B., & Crystal, R. G. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0351-1 · Cited by 161
Collard, H. R., Ryu, J. H., Douglas, W. W., Schwarz, M. I., Curran‐Everett, D., King, T. E., & Brown, K. K. (2004) · CHEST Journal · doi:10.1378/chest.125.6.2169 · Cited by 159
Self-citationSynergy between A2B Adenosine Receptors and Hypoxia in Activating Human Lung Fibroblasts
Zhong, H., Belardinelli, L., Maa, T., & Zeng, D. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0103oc · Cited by 146
Somatic Stem Cell Marker Prominin‐1/CD133 Is Expressed in Embryonic Stem Cell–Derived Progenitors
Kania, G., Corbeil, D., Fuchs, J., Tarasov, K. V., Błyszczuk, P., Huttner, W. Β., Boheler, K. R., & Wobus, A. M. (2005) · Stem Cells · doi:10.1634/stemcells.2004-0232 · Cited by 134
Colchicine, D-Penicillamine, and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis
Selman, M., Carrillo, G., Salas, J., Pérez‐Padilla, R., Pèrez-Chavira, R., Sansores, R., & Chapela, R. (1998) · CHEST Journal · doi:10.1378/chest.114.2.507 · Cited by 128
Self-citationSurfactant Protein A Predicts Survival in Idiopathic Pulmonary Fibrosis
McCormack, F. X., King, T. E., Bucher, B. L., Nielsen, L., Mason, R. J., & McCormac, F. X. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.2.7633738 · Cited by 125
Self-citationLung function estimates in idiopathic pulmonary fibrosis: the potential for a simple classification
Egan, J. J., Martínez, F. J., Wells, A. U., & Williams, T. (2005) · Thorax · doi:10.1136/thx.2004.035436 · Cited by 119
Heguy, A., O’Connor, T. P., Luettich, K., Worgall, S., Cieciuch, A., Harvey, B., Hackett, N. R., & Crystal, R. G. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0008-2 · Cited by 103
Host Determinants in HIV Infection and Disease: Part 1: Cellular and Humoral Immune Responses*
Hogan, C., & Hammer, S. M. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-9_part_1-200105010-00013 · Cited by 102
Practical Approaches to Analyzing Results of Microarray Experiments
Kaminski, N., & Friedman, N. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.27.2.f247 · Cited by 96
Self-citationChunn, J. L., Mohsenin, A., Young, H. W. J., Lee, C. G., Elias, J. A., Kellems, R. E., & Blackburn, M. R. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00258.2005 · Cited by 82
Bleomycin-induced Pulmonary Fibrosis Is Attenuated in γ-Glutamyl Transpeptidase–Deficient Mice
Pardo, A., Ruiz, V., Arreola, J. L., Ramı́rez, R., Cisneros, J., Gaxiola, M., Barrios, R. J., Kala, S. V., Lieberman, M. W., & Selman, M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200209-1007oc · Cited by 61
Self-citationEffects of Aerobic Training on Gene Expression in Skeletal Muscle of Elderly Men
Radom‐Aizik, S., Hayek, S., Shahar, I., Rechavi, G., Kaminski, N., & Ben-Dov, I. (2005) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000181838.96815.4d · Cited by 51
Self-citationRegulation of receptor for advanced glycation end products during bleomycin-induced lung injury.
Hanford, L. E., Fattman, C. L., Shaefer, L. M., Enghild, J. J., Valnickova, Z., & Oury, T. D. (2003) · PubMed · Cited by 51
Cigarette smoke exposure potentiates bleomycin-induced lung fibrosis in guinea pigs
Cisneros, J., Gaxiola, M., Ramos, C., Selman, M., & Pardo, A. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00074.2003 · Cited by 49
Self-citationHyde, D. M., King, T. E., Mcdermott, T., et al. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/146.4.1042 · Cited by 49
Self-citationCarr, B., Wan, J., Hines, R. N., & Yost, G. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300319200 · Cited by 45
Marshall, A., Rushbrook, S., Morris, L. S., Scott, I. S., Vowler, S. L., Davies, S. E., Coleman, N., & Alexander, G. (2005) · Liver Transplantation · doi:10.1002/lt.20347 · Cited by 17
Cited by
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
Self-citationKing, T. E., Pardo, A., & Selman, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60052-4 · Cited by 2,194
Self-citationClinical course and prediction of survival in idiopathic pulmonary fibrosis
Ley, B., Collard, H. R., & King, T. E. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0894ci · Cited by 1,765
Self-citationMartinez, F. J., Collard, H. R., Pardo, A., Raghu, G., Richeldi, L., Selman, M., Swigris, J. J., Taniguchi, H., & Wells, A. U. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.74 · Cited by 1,388
Self-citationCharacterisation of COPD heterogeneity in the ECLIPSE cohort
the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators, Agusti, A., Calverley, P. M., Celli, B., Coxson, H. O., Edwards, L. D., Lomas, D. A., MacNee, W., Miller, B. E., Rennard, S., et al. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-122 · Cited by 1,157
“On the other hand, the lack of relationship between age and severity of airflow limitation may also indicate that the ECLIPSE subjects had previously had a wide range of lung function decline, a possibility that would be perfectly in line with the accepted pathophysiological models of COPD [1,12] because it would sugg…”
Result
Metadata
- Authors
- Selman, M., Carrillo, G., Estrada, A., Mejia, M., Becerril, C., Cisneros, J., Gaxiola, M., Pérez-Padilla, R., Navarro, C., Richards, T., Dauber, J., King, T. E., Pardo, A., & Kaminski, N.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-05-30
- Volume
- 2
- Issue
- 5
- Pages
- e482
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1970379805
- Cited by
- 270
- References
- 48
- FWCI
- 14.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.